Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-11

FDA Approved: OVIDREL — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OVIDREL (chorionic gonadotropin alfa) from EMD Serono, Inc., updating the labeling for its use in triggering ovu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ovidrel (Choriogonadotropin alfa)

Snippet

SUPPL AP for OVIDREL (CHORIOGONADOTROPIN ALFA)